Precision Medicine Assays Personalized Medicine

Sphera Platform

The SpheraTM platform combines PBA’s innovative organoid cell culture technology with AI software to provide key measures of drug efficacy in a personalized and biologically-relevant model system. Sphera shows a robust positive correlation with standard clinical endpoints and clinical results and is able to identify subtle differences in efficacy between similar drugs, as well as different concentrations of the same drug, in a patient-specific manner. PBA is deploying Sphera at scale to identify and optimize new and existing drugs for a range of indications.